Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Iida

Showing results (231-240 of 290) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
British Journal of Haematology|November 22, 2011
CD48 as a novel molecular target for antibody therapy in multiple myelomaNaoki Hosen, Hiroyoshi Ichihara, Atsuko Mugitani, et al.
Nature Communications|December 15, 2021
Depletion of central memory CD8<sup>+</sup> T cells might impede the antitumor therapeutic effect of MogamulizumabYuka Maeda, Hisashi Wada, Daisuke Sugiyama, et al.
Blood|June 25, 2017
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphomaTomoko Narita, Takashi Ishida, Asahi Ito, et al.
International Journal of Hematology|November 25, 2024
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Cancer Science|February 26, 2018
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myelomaShinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, et al.
Nature Communications|May 3, 2022
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphomaStella Amanda, Tze King Tan, Jolynn Zu Lin Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2020
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 TrialMeletios A Dimopoulos, Ivan Špička, Hang Quach, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
International Journal of Hematology|February 15, 2023
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphomaTomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Pageof 29

Showing results (231-240 of 290) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/LymphomaAyako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
British Journal of Haematology|November 22, 2011
CD48 as a novel molecular target for antibody therapy in multiple myelomaNaoki Hosen, Hiroyoshi Ichihara, Atsuko Mugitani, et al.
Nature Communications|December 15, 2021
Depletion of central memory CD8<sup>+</sup> T cells might impede the antitumor therapeutic effect of MogamulizumabYuka Maeda, Hisashi Wada, Daisuke Sugiyama, et al.
Blood|June 25, 2017
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphomaTomoko Narita, Takashi Ishida, Asahi Ito, et al.
International Journal of Hematology|November 25, 2024
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Cancer Science|February 26, 2018
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myelomaShinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, et al.
Nature Communications|May 3, 2022
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphomaStella Amanda, Tze King Tan, Jolynn Zu Lin Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2020
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 TrialMeletios A Dimopoulos, Ivan Špička, Hang Quach, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2015
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, et al.
International Journal of Hematology|February 15, 2023
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphomaTomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Pageof 29